1. Home
  2. GNFT vs SFST Comparison

GNFT vs SFST Comparison

Compare GNFT & SFST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GNFT
  • SFST
  • Stock Information
  • Founded
  • GNFT 1999
  • SFST 1999
  • Country
  • GNFT France
  • SFST United States
  • Employees
  • GNFT 167
  • SFST N/A
  • Industry
  • GNFT Biotechnology: Biological Products (No Diagnostic Substances)
  • SFST Major Banks
  • Sector
  • GNFT Health Care
  • SFST Finance
  • Exchange
  • GNFT Nasdaq
  • SFST Nasdaq
  • Market Cap
  • GNFT 189.6M
  • SFST 344.3M
  • IPO Year
  • GNFT 2019
  • SFST 1999
  • Fundamental
  • Price
  • GNFT $3.80
  • SFST $40.65
  • Analyst Decision
  • GNFT Strong Buy
  • SFST Buy
  • Analyst Count
  • GNFT 1
  • SFST 1
  • Target Price
  • GNFT $13.00
  • SFST $44.00
  • AVG Volume (30 Days)
  • GNFT 9.8K
  • SFST 18.6K
  • Earning Date
  • GNFT 09-19-2024
  • SFST 01-16-2025
  • Dividend Yield
  • GNFT N/A
  • SFST N/A
  • EPS Growth
  • GNFT N/A
  • SFST N/A
  • EPS
  • GNFT 0.47
  • SFST 1.73
  • Revenue
  • GNFT $86,225,222.00
  • SFST $90,166,000.00
  • Revenue This Year
  • GNFT $155.44
  • SFST N/A
  • Revenue Next Year
  • GNFT N/A
  • SFST $13.55
  • P/E Ratio
  • GNFT $7.59
  • SFST $23.01
  • Revenue Growth
  • GNFT 175.45
  • SFST 3.18
  • 52 Week Low
  • GNFT $3.31
  • SFST $24.98
  • 52 Week High
  • GNFT $6.42
  • SFST $45.91
  • Technical
  • Relative Strength Index (RSI)
  • GNFT 29.24
  • SFST 43.15
  • Support Level
  • GNFT $3.63
  • SFST $39.47
  • Resistance Level
  • GNFT $3.88
  • SFST $42.99
  • Average True Range (ATR)
  • GNFT 0.10
  • SFST 1.30
  • MACD
  • GNFT 0.02
  • SFST -0.58
  • Stochastic Oscillator
  • GNFT 15.30
  • SFST 26.34

About GNFT GENFIT S.A.

Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of innovative medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.

About SFST Southern First Bancshares Inc.

Southern First Bancshares Inc is a bank holding company. The company engaged in the business of accepting demand deposits and savings deposits insured by the Federal Deposit Insurance Corporation (the "FDIC"), and providing commercial, consumer and mortgage loans to the general public of which a majority of the revenue is derived from the Commercial and Retail Banking segment which includes the provision of traditional deposit and lending products and services to its commercial and retail banking clients.

Share on Social Networks: